The user is concerned about hairloss despite using oral finasteride, oral minoxidil, and topical minoxidil. They are seeking advice on additional blood tests to identify potential causes.
Winlevi is being considered for hairloss by someone who wants to avoid systemic hormonal changes. Minoxidil, finasteride, and RU58841 are also mentioned as treatments.
Transgender hormone therapy, including Estradiol Valerate, Spironolactone, and Progesterone Micronized, can reverse male pattern baldness and improve hair health. The user shares their positive experience with hair regrowth after transitioning from male to female.
A non-binary individual experienced hairloss after stopping hormone replacement therapy and is using oral Dutasteride, oral Minoxidil, and ketoconazole shampoo. They are hopeful for regrowth but may use wigs due to the high cost and uncertain effectiveness of additional treatments like mesotherapy and PRP.
Caffeine might raise stress hormones, potentially worsening hairloss. Telogen effluvium is often misattributed to minor stressors rather than significant life events.
Stress can lead to hairloss by affecting hair-follicle stem cells, and this loss is harder to recover from if one has male pattern baldness (MPB). Treatments like finasteride and minoxidil are used to address hairloss, but stress-related hairloss differs from androgenic alopecia.
Parasites in the gut may contribute to hairloss by depleting essential nutrients and disrupting hormone balance. An imbalance of hormones, not just DHT, could be a factor in androgenic alopecia.
The conversation discusses hairloss treatment options, focusing on finasteride and its potential effects on gynecomastia. The user is considering finasteride while managing hormone levels with supplements like boron, vitamin D, zinc, magnesium, and P5P, and is advised to consult an endocrinologist for further evaluation.
OP shares their experience with PCOS-related hairloss, highlighting that addressing vitamin D and ferritin deficiencies, managing hormones with spironolactone, and using gentle hair care products helped improve their condition. They advise against relying on "miracle" hair oils and emphasize the importance of medical evaluation and a combined approach to treatment.
The user is experiencing hairloss and forehead swelling, considering Botox and PRP as treatments, and has been on finasteride for three weeks. They believe tension, not just hormones, contributes to their hairloss and are exploring non-hormonal solutions.
A woman experiencing hairloss is trying iron, biotin, and B12 supplements, increasing meat intake, and improving hydration to address her condition. Another person suggests checking vitamin D levels, stress, thyroid, and hormones, and recommends seeing a dermatologist for a proper diagnosis.
PP405 is a new hairloss treatment in phase 2 trials that may promote hair growth by increasing lactate production and activating hair follicle stem cells. It could potentially replace hormone-disrupting treatments like Minoxidil and finasteride.
GT20026 is discussed as a potential treatment for hairloss that targets androgen receptors without affecting hormone levels, but it may not promote significant regrowth. It is expected to be available by 2028, with other treatments like Breezula and Clascoterone also mentioned.
Creatine does not cause hairloss, despite many users reporting personal experiences of hair shedding. Scientific evidence shows no link between creatine and increased hairloss or hormone changes.
Viviscal is not effective for preventing hairloss; finasteride or dutasteride and minoxidil are recommended instead. Hormone replacement therapy, particularly spironolactone, may also help reduce hairloss for trans women.
Spironolactone is more potent and lowers testosterone and DHT, while dutasteride only impacts DHT. For female hairloss, checking hormones and considering treatments like oral minoxidil, spironolactone, or topical minoxidil is recommended.
Finasteride is more accepted than hair systems because it is less visible and maintains natural hair. Treatments like minoxidil and finasteride are commonly used for hairloss, but opinions on hair systems vary.
Amplifica's new injectable treatment for androgenetic alopecia shows a 15% increase in hair thickness and coarseness in 60 days. The treatment is in early human trials and offers a promising alternative to hormone-related hairloss treatments.
Prolactin and cortisol are identified as key factors in hairloss, with stress hormones impacting hair shedding. Finasteride and minoxidil are effective treatments, while DHT's role and individual sensitivity are significant factors.
Low testosterone and estradiol may contribute to hairloss, and blocking DHT without sufficient hormone levels might hinder regrowth. The discussion highlights the importance of hormone balance, with some considering supplements and lifestyle changes to support hair health.
The user experiencing diffuse hairloss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hairloss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hairloss, while another user suggests androgenic alopecia and androgens are likely the main cause of hairloss.
The conversation is about a person experiencing hairloss from steroid use, considering treatments like RU58841, dutasteride, and Nizoral, while avoiding finasteride and Minoxidil due to concerns about hormones and hypertension. The consensus suggests using dutasteride or finasteride, as Nizoral alone is not effective.
The conversation discusses designing a study to examine the relationship between creatine and hairloss, suggesting groups with different creatine and finasteride usage. It emphasizes the need for consistent scalp examinations, DHT level measurements, and considers the impact of exercise on hormone levels.
Dutasteride effectively stops hairloss but can cause side effects like sexual dysfunction, muscle mass changes, and testicle shrinkage. Adjusting the dosage may help manage these side effects, but long-term health effects remain a concern.
The conversation discusses starting low-dose oral finasteride for hairloss, considering hormone levels and potential side effects like gynecomastia. Suggestions include using DIM for estradiol, vitamin B6 for prolactin, and lifestyle changes to optimize hormone profiles before starting treatment.
The conversation discusses whether individuals using hairloss treatments like Dutasteride (Dut) or Finasteride (Fin) should regularly check their hormone levels through bloodwork. Some argue it's important to monitor the effects of these medications on hormone levels, while others believe it's unnecessary if there are no side effects, citing cost and practicality concerns.
The conversation discusses using topical liposomal finasteride for hairloss, with concerns about high DHT levels. The user's DHT level is above the normal range, which may affect hair health.
A user is considering starting finasteride for hairloss and is concerned about hormone levels potentially affecting side effects. They plan to consult a doctor and are curious if their current hormone levels indicate any risks.
A 29-year-old male experienced hairloss and reduced libido after heavy drinking from 2020 to 2024, and began using finasteride (1mg daily) and minoxidil (5% topical, once daily) in January 2026, noticing thicker hair but no new regrowth after three months. He also introduced derma rolling in February and plans to continue treatment for 6–12 months before fully assessing results.
People discussed hairloss treatments, including finasteride, minoxidil, and microneedling, with varying results and concerns about genetics and hormone levels. Some users shared personal experiences with medication dosages and side effects, while others mentioned the impact of stress on hairloss.